Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Prostate Cancer

  Free Subscription


1 BMC Cancer
3 Eur Urol
2 Int J Cancer
1 Int J Radiat Oncol Biol Phys
1 Int J Urol
1 J Urol
2 Prostate

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    BMC Cancer

  1. SHARMA D, Osapoetra LO, Faltyn M, Giles A, et al
    In vivo assessment of prostate cancer response using quantitative ultrasound characterization of ultrasonic scattering properties.
    BMC Cancer. 2021;21:991.
    PubMed         Abstract available

    Eur Urol

  2. KWAN EM, Spain L, Anton A, Gan CL, et al
    Avelumab Combined with Stereotactic Ablative Body Radiotherapy in Metastatic Castration-resistant Prostate Cancer: The Phase 2 ICE-PAC Clinical Trial.
    Eur Urol. 2021 Sep 4. pii: S0302-2838(21)01979.
    PubMed         Abstract available

  3. HOPSTAKEN JS, Bomers JGR, Sedelaar MJP, Valerio M, et al
    An Updated Systematic Review on Focal Therapy in Localized Prostate Cancer: What Has Changed over the Past 5 Years?
    Eur Urol. 2021 Sep 3. pii: S0302-2838(21)01949.
    PubMed         Abstract available

  4. THURTLE D, Jenkins V, Freeman A, Pearson M, et al
    Clinical Impact of the Predict Prostate Risk Communication Tool in Men Newly Diagnosed with Nonmetastatic Prostate Cancer: A Multicentre Randomised Controlled Trial.
    Eur Urol. 2021 Sep 4. pii: S0302-2838(21)01933.
    PubMed         Abstract available

    Int J Cancer

  5. LI X, Cheng K, Li X, Zhou Y, et al
    Phase I clinical trial of HC-1119: A deuterated form of enzalutamide.
    Int J Cancer. 2021;149:1473-1482.
    PubMed         Abstract available

  6. KOSTOS L, Hong W, Lee B, Tran B, et al
    Cancer clinical trial vs real-world outcomes for standard of care first-line treatment in the advanced disease setting.
    Int J Cancer. 2021;149:409-419.
    PubMed         Abstract available

    Int J Radiat Oncol Biol Phys

  7. JONES CU, Pugh SL, Sandler HM, Chetner MP, et al
    Adding short-term androgen deprivation therapy to RT in men with localized prostate cancer: long-term update of the NRG/RTOG 9408 randomized clinical trial.
    Int J Radiat Oncol Biol Phys. 2021 Sep 1. pii: S0360-3016(21)02724.
    PubMed         Abstract available

    Int J Urol

    Editorial Comment to Comparison of disease-specific quality of life in prostate cancer patients treated with low-dose-rate brachytherapy: A randomized controlled trial of silodosin versus naftopidil.
    Int J Urol. 2021 Sep 8. doi: 10.1111/iju.14690.

    J Urol

    Urological Oncology: Prostate Cancer.
    J Urol. 2021 Sep 9:101097JU0000000000002226. doi: 10.1097/JU.0000000000002226.


  10. MANGOSH TL, Grabowska MM, Taylor DJ
    SLX4IP N-terminus dictates telomeric localization in ALT-like castration-resistant prostate cancer cell lines.
    Prostate. 2021 Sep 7. doi: 10.1002/pros.24225.
    PubMed         Abstract available

  11. MATSUDA T, Miyata Y, Nakamura Y, Otsubo A, et al
    Pathological significance and prognostic role of LATS2 in prostate cancer.
    Prostate. 2021 Sep 7. doi: 10.1002/pros.24226.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Prostate Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.